A detailed history of Rothschild Capital Partners, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Rothschild Capital Partners, LLC holds 5,066 shares of BSX stock, worth $527,471. This represents 0.14% of its overall portfolio holdings.

Number of Shares
5,066
Previous 4,126 22.78%
Holding current value
$527,471
Previous $368,000 38.86%
% of portfolio
0.14%
Previous 0.09%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
$89.38 - $106.18 $84,017 - $99,809
940 Added 22.78%
5,066 $511,000
Q4 2024

Feb 14, 2025

BUY
$83.62 - $91.5 $345,016 - $377,529
4,126 New
4,126 $368,000
Q3 2016

Sep 06, 2018

BUY
N/A
124,865
124,865 $2.97 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $149B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Rothschild Capital Partners, LLC Portfolio

Follow Rothschild Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rothschild Capital Partners, LLC with notifications on news.